InspireMD, Inc. (NYSE:NSPR) has a beta value of 2.4 and has seen 914,158 shares traded in the last trading session. The company, currently valued at $13.43 Million, closed the last trade at $0.36 per share which meant it lost $0 on the day or 1.01% during that session. The NSPR stock price is -355.56% off its 52-week high price of $1.64 and 22.22% above the 52-week low of $0.28. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.01 Million shares traded. The 3-month trading volume is 1.37 Million shares.
The consensus among analysts is that InspireMD, Inc. (NSPR) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 2 have rated it as a Hold, with 2 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.06.
InspireMD, Inc. (NYSE:NSPR) trade information
Sporting 1.01% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Nov 16 when the NSPR stock price touched $0.38 or saw a rise of 5.42%. Year-to-date, InspireMD, Inc. shares have moved -66.72%, while the 5-day performance has seen it change 2.36%. Over the past 30 days, the shares of InspireMD, Inc. (NYSE:NSPR) have changed -7.89%. Short interest in the company has seen 712.82 Million shares shorted with days to cover at 520.31.
Wall Street analysts have a consensus price target for the stock at $0.85, which means that the shares’ value could jump 136.11% from current levels. The projected low price target is $0.7 while the price target rests at a high of $1. In that case, then, we find that the current price level is +177.78% off the targeted high while a plunge would see the stock lose 94.44% from current levels.
InspireMD, Inc. (NSPR) estimates and forecasts
Figures show that InspireMD, Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -57.13% over the past 6 months, with this year growth rate of -91.67%, compared to 13.4% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 89.5% and 81.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be -12.7%.
2 analysts offering their estimates for the company have set an average revenue estimate of $1.1 Million for the current quarter. 1 have an estimated revenue figure of $1Million for the next quarter concluding in March 01, 2021. Year-ago sales stood $1.01 Million and $1.03 Million respectively for this quarter and the next, and analysts expect sales will grow by 8.6% for the current quarter and -3.3% for the next.
Earnings growth for 2020 is a modest +71.2%.
InspireMD, Inc. (NYSE:NSPR)’s Major holders
Insiders own 12.03% of the company shares, while shares held by institutions stand at 3.07% with a share float percentage of 3.49%. Investors are also buoyed by the number of investors in a company, with InspireMD, Inc. having a total of 18 institutions that hold shares in the company. The top two institutional holders are Sabby Management, LLC with over 243.9 Thousand shares worth more than $77.39 Thousand. As of September 29, 2020, Sabby Management, LLC held 0.66% of shares outstanding.
The other major institutional holder is Wedbush Securities Inc, with the holding of over 230.51 Thousand shares as of September 29, 2020. The firm’s total holdings are worth over $73.14 Thousand and represent 0.62% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Bridgeway Funds Inc-Ultra Small Company Market Fund and Vanguard Extended Market Index Fund. As of June 29, 2020, the former fund manager holds about 0.07% shares in the company for having 25000 shares of worth $11.63 Thousand while later fund manager owns 7.47 Thousand shares of worth $3.47 Thousand as of June 29, 2020, which makes it owner of about 0.02% of company’s outstanding stock.